Benitec Biopharma Statistics
Total Valuation
BNTC has a market cap or net worth of $431.49 million. The enterprise value is $247.61 million.
| Market Cap | 431.49M |
| Enterprise Value | 247.61M |
Important Dates
The next estimated earnings date is Monday, September 21, 2026, before market open.
| Earnings Date | Sep 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BNTC has 34.35 million shares outstanding. The number of shares has increased by 37.41% in one year.
| Current Share Class | 34.35M |
| Shares Outstanding | 34.35M |
| Shares Change (YoY) | +37.41% |
| Shares Change (QoQ) | +7.43% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 56.06% |
| Float | 17.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 63.22 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 56.82, with a Debt / Equity ratio of 0.00.
| Current Ratio | 56.82 |
| Quick Ratio | 56.43 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.58% and return on invested capital (ROIC) is -20.60%.
| Return on Equity (ROE) | -29.58% |
| Return on Assets (ROA) | -19.93% |
| Return on Invested Capital (ROIC) | -20.60% |
| Return on Capital Employed (ROCE) | -25.36% |
| Weighted Average Cost of Capital (WACC) | 5.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.19M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.40% in the last 52 weeks. The beta is 0.26, so BNTC's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +0.40% |
| 50-Day Moving Average | 12.31 |
| 200-Day Moving Average | 12.22 |
| Relative Strength Index (RSI) | 50.24 |
| Average Volume (20 Days) | 147,672 |
Short Selling Information
The latest short interest is 2.15 million, so 6.25% of the outstanding shares have been sold short.
| Short Interest | 2.15M |
| Short Previous Month | 2.27M |
| Short % of Shares Out | 6.25% |
| Short % of Float | 11.98% |
| Short Ratio (days to cover) | 24.46 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -46.60M |
| Pretax Income | -41.54M |
| Net Income | -41.54M |
| EBITDA | -46.54M |
| EBIT | -46.60M |
| Earnings Per Share (EPS) | -$0.93 |
Balance Sheet
The company has $184.76 million in cash and $876,000 in debt, with a net cash position of $183.89 million or $5.35 per share.
| Cash & Cash Equivalents | 184.76M |
| Total Debt | 876,000 |
| Net Cash | 183.89M |
| Net Cash Per Share | $5.35 |
| Equity (Book Value) | 183.33M |
| Book Value Per Share | 5.34 |
| Working Capital | 182.74M |
Cash Flow
In the last 12 months, operating cash flow was -$19.79 million and capital expenditures -$26,000, giving a free cash flow of -$19.82 million.
| Operating Cash Flow | -19.79M |
| Capital Expenditures | -26,000 |
| Depreciation & Amortization | 55,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -19.82M |
| FCF Per Share | -$0.58 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BNTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.41% |
| Shareholder Yield | -37.41% |
| Earnings Yield | -9.63% |
| FCF Yield | -4.59% |
Analyst Forecast
The average price target for BNTC is $24.17, which is 92.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.17 |
| Price Target Difference | 92.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.
| Last Split Date | Jul 26, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:17 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |